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Abstract  
Objective: Between 2012 and 2017 dementia case-finding was routinely carried out on 
people aged 75 and over with unplanned admissions to acute hospitals across England.  The 
assumption was that this would lead to better planning of care and treatment for patients 
with dementia following discharge from hospital.  However, little is known about the 
experiences of patients and carers or the impacts on other health services.  This study 
explored the impact of dementia case-finding on older people and their families and on 
their use of services.  
Design: Thematic content analysis was conducted on qualitative interview data and costs 
associated with service use were estimated.  Measures included the Mini-Mental State 
Examination (MMSE), the EuroQol (EQ-5D-5L) quality of life scale and a modified Client 
Service Receipt Inventory (CSRI).  
Setting: Four counties in the East of England. 
Participants:  People aged ≥75-years who had been identified by case-finding during an 
unplanned hospital admission as warranting further investigation of possible dementia and 
their family carers.   
Results:  We carried out 28 interviews, including 19 joint patient-carer(s), 5 patient only and 
4 family carer interviews.  Most patients and carers were unaware that memory 
assessments had taken place, with many families not being informed or involved in the 
process.  Participants had a variety of views on memory testing in hospital and had concerns 
about how hospitals carried out assessments and communicated results.  Overall, case-
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finding did not lead to general practitioner (GP) follow up after discharge home or lead to 
referral for further investigation. Few services were initiated because of dementia case-
finding in hospital. 
Conclusions:  This study shows that dementia case-finding may not lead to increased GP follow up 
or service provision for patients after discharge from hospital.  There is a need for a more evidence-
based approach to the initiation of mandatory initiatives such as case-finding that inevitably 
consume stretched human and financial resources. 
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Strengths and limitations 
• This is one of the first studies to investigate the impacts of a mandatory policy 
introduced nationwide without prior piloting, feasibility testing or evidence of 
effectiveness – case-finding for dementia amongst all hospital patients aged ≥75 
whose admission was unplanned.  
• Qualitative research methods using topic-guided interviews enabled in-depth 
exploration of personal experiences of dementia case-finding both during a hospital 
stay and of health and care services used subsequently. 
• As the focus was on those identified by case-finding while in-patients, the study 
design sought to interview relatives/family carers as well as these former patients 
themselves. 
• Study limitations include a small sample size and a reliance on participants’ self-
reporting of service use data. 
• It was beyond the scope of this study to track actual service use costs so our cost 
estimation draws on published unit costs data.   
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Introduction 
Pre-existing cognitive impairment in hospitalised older people is estimated at between 15% 
to 42%.1-5  Many of these patients may not have had a previous diagnosis of dementia.3 6 
This has led to concerns about providing adequate care for older people with dementia, and 
policy development to improve the identification of dementia in older people in hospital.7-10  
In the English National Health Service (NHS) initiatives were introduced to increase 
awareness and improve the identification of dementia in secondary care.11-14  In 2012-2013, 
the Department of Health introduced a mandatory policy requiring that all hospitals across 
England routinely carry out cognitive assessments with ≥75-year-olds who have had an 
emergency admission and that those identified as potentially having dementia are 
appropriately assessed and referred.  The rationale for case-finding in hospital was that 
early identification of cognitive impairment would lead to a timely diagnosis, informed 
patient care and improved health outcomes for older people.15 16 This was implemented in 
the absence of any randomised control trial evidence to know the impact of such an 
approach.  
Although cognitive assessment tests can detect undiagnosed dementia,17-19 dementia does 
not fit the criteria for screening programmes and there are concerns over the impacts of 
case-finding as well as screening for dementia.20 21  Moreover, in practice the distinction 
between screening and case-finding is often not clear to clinicians and the public.22 23  
Healthcare professionals have been reported as viewing case-finding as a financially and 
politically driven policy with little or no evaluation of patient outcomes.24-27  In a previous 
paper we reported how the variation in approaches to dementia case-finding has meant 
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that information communicated to primary care is inconsistent and has an impact on how 
well general practitioners (GPs) can effectively plan patients’ treatment and care once they 
are home in the community.27   
Little is known about the wider impacts of dementia case-finding on patient and carer 
experiences and on their access to dementia-related or other care services.  The overall 
aims of this study were to explore the impacts of dementia case-finding on older people 
identified by hospital case-finding as warranting further investigation, their family carers 
and their use of health service and care services.  For example, were they being re-assessed 
in primary care and, if appropriate, receiving specialist referral, being given a diagnosis or 
receiving new services? 
 
Methods 
This study involved in-depth exploratory interviews with former hospital patients and their 
family carers.  A range of qualitative and quantitative data was collected.  This was the 
second phase of the CASCADE study (CASe finding in hospitals - impacts on CAre for people 
with DEmentia).28  Phase 1 results are reported in full elsewhere.27 
We recruited former patients of two participating hospitals in the East of England.  Eligible 
patients were aged at least 75-years-old, had been acutely admitted 6-12 months 
previously, had been flagged by dementia case-finding as warranting further investigation 
about their cognition, and were community dwelling.  Family carers of these patients were 
also recruited for interviews.  Invitation letters were sent to eligible participants from the 
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hospital elderly medicine consultant under whose care they had been admitted, together 
with an information sheet and response form.  
Semi-structured interview schedules were developed to gather patient and family carers’ 
experiences and perceptions of dementia case-finding and the impacts of case-finding on 
their subsequent treatment and care (supplementary file 1).  Demographic data was 
collected and the Mini-Mental State Examination MMSE29 and EuroQol (EQ-5D-5L)30 
validated scales were used to characterise patients’ cognition and health related quality of 
life (HRQoL) respectively.  For the analysis, those with a score below 24 on the MMSE were 
classified as cognitively impaired and those with a score of 24 and above were categorised 
as cognitively intact.  EuroQol’s validated proxy version of the EQ-5D-5L was undertaken 
with carers to characterise patients in the minority of cases when a carer were interviewed 
separately from the former patient.  Completed EQ-5D-5Ls were scored against the 
published algorithm and results from the scale’s five domains were used to characterise 
participants’ levels of difficulty in each.31  Data were collected on patients’ self-reported use 
of inpatient and outpatient services, day activity services since the index hospital admission, 
community care services, and current medication.  Service use was collected using relevant 
sections of the Client Service Receipt Inventory (CSRI)32 using ‘Visio’ timelines33 to facilitate 
recall and recording of events such as referrals or the start of new services.  Two female 
researchers (A-MB, JF) carried out the interviews in the patients’ and family carers’ homes 
across four counties in the East of England (Bedfordshire, Cambridgeshire, Essex and 
Hertfordshire).  Interviews lasted about an hour.  Participants gave signed consent before 
the interview and interviews were tape recorded, transcribed and anonymised.   
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An initial thematic framework was developed by the research team (A-MB, FB, JF) which 
was informed by the research questions and coding a selection of transcripts.  The 
codeframe and the anonymised transcripts were transferred into NVivo V.11 and the data 
analysed using thematic content analysis.34  This enabled the key features of patients’ and 
carers’ experiences to be elicited from the data.  Quantitative data was entered into an 
Excel spreadsheet.  Ethical approval was obtained from South Central – Oxford C Research 
Ethics Committee (reference: 15/SC/0728). 
Estimation of service costs 
Service use, reported by means of the modified CSRI, were costed using several sources.  For 
community based health care we obtained cost per hour of staff time from a published 
source of unit cost data.35  Estimates of average contact time and the proportion of health 
care professionals time that would be spent on direct client contact were used to estimate a 
cost per contact.36  For some contacts respondents reported frequency rather than numbers 
of contacts, for example 3 times a week.  To convert this to numbers of contacts we 
required a time period, this was taken as the time difference between the date of discharge 
and the date of the interview.  This duration therefore varied between individuals. 
Costs for secondary care were obtained from NHS references costs.37  For elective inpatient 
admissions we used a weighted average of either elective short stays or long stays.  This 
gave estimates for the costs of elective stages of £616 for an elective short stay and £3,058 
for an elective long stay.  For non-elective admissions, again a weighted average was 
obtained from NHS references costs, this was £3,058 for long stays.  For accident and 
emergency (A&E) visits a weighted average of £204 was used.  A detailed estimate of the 
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cost of memory services was available from the literature.35  This gave a cost per client of 
£1,218.  However, this was based on a different NHS trust and it is not clear how 
representative this would be of the service provided to participants in the current study. For 
memory related drugs a price was obtained from a published source.38  All costs are in UK 
pound sterling for the year 2015/16. As the period of analysis was for one year only 
discounting was not used. 
Patient and public involvement 
Two well-established patient and public involvement groups were involved in the study; the 
University of Hertfordshire Patient Involvement in Research Group, and the University of 
Cambridge’s Public Involvement in Research into Ageing and Dementia Group.  Four 
members of these groups acted as a User Reference Group for the study.  They provided 
feedback on the aims of the study, study documents such as patient information sheets, and 
commented on preliminary findings from the qualitative analysis.   
FINDINGS  
We conducted a total of 28 interviews involving 49 participants.  Of those, 24 were former 
patients who had been identified as having a concern about their memory during an 
unplanned hospital admission and 25 were carers.  Nineteen interviews were held jointly 
with the patient and their family carer(s). All patients had received a memory assessment 
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during their hospital stay which indicated that there was a cause for concern over their 
cognition which warranted further investigation.   
Table 1 summarises descriptive characteristics of the former patients in our study. Both 
their median and mean age  was 85 (range 79-94) and just over half (53%) were women.  
The median MMSE score was 23.0 (IQR 16.5-26) indicating mild cognitive impairment, but 
there was considerable variation with scores ranging between 6-30. Patients had 
considerable levels of physical impairment and difficulty with activities of daily living, for 
example nearly half and over a third had severe problems and were unable to walk or wash 
and dress themselves.  The EQ-5D-5L scoring system31 can provide scores between one and -
0.594.  This range has anchor points where 1 is considered to be full health and 0 is 
considered to be equivalent of dead.  The scoring algorithm allows some scores to be lower 
than zero, i.e., worse than dead. Twenty-four former patients provided a value for their own 
health state and the mean value for these individuals was 0.39 (95%CI: 0.25-0.52).  There 
were 25 carers who provided a valuation of their own health with a mean value 0.78 (95% 
CI: 0.69 – 0.86).  For comparison, population norms are available for those aged over 75 for 
the EQ-5D-3L39 which give values of 0.75 and 0.71 for males and females respectively.  The 
value obtained here for former patients is considerably below these values.  
Table 1: Characteristics of the former patient sample 
Full sample n=28 
Age           Mean and median 
                  (Range) 
85, 85 
(79-94) 
% Female 53% 
MMSE      Median (IQR) 
                  Mean (SD) 
23 (16.5-26) 
20.8 (6.8) 
Sample with EQ-5D-5L  n=24 
Severe problems walking / unable to walk 44% 
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Severe problems washing and dressing self / unable to wash & dress self 37% 
Severe problems doing usual activities / unable to do usual activities 52% 
Severe / extreme pain or discomfort 4% 
Severely / extremely anxious or depressed 15% 
EQ-5D-5L valuation (95%CI) 0.39 (0.25 - 0.52) 
 
Impacts of dementia case-finding on service use  
Nine people had been assessed post discharge either in a memory clinic or by an old age 
psychiatrist but two of these had already been referred by their GP prior to hospital 
admission.  For the seven people who had been referred to memory services since hospital 
discharge it was not clear whether these referrals were a result of hospital case-finding or 
not.  Patients referred for investigation since discharge (n=7) generally had lower MMSE 
scores than those not referred (MMSE of 17 (IQR 15 - 22) versus 25 (IQR 19 - 26)).  In the 
non-referred group, two patients had MMSE scores that indicated severe cognitive 
impairment and five had scores indicating moderate cognitive impairment.  Five patients 
who were referred since case-finding had been started on dementia medication (e.g. 
Donepezil, Memantine), but two of these had stopped taking this medication within a 
fortnight because of side effects. 
Estimates of the costs incurred by former patients of dementia case-finding for the period 
between index stay discharge and interview are given in Table 2.  We had available data for 
28 former patients, 24 where the patient was present at interview and 4 where only a carer 
was present.  Precise costing was not generally possible, so these costs should be taken as 
indicative.  This group have a mean estimated cost of £5,180 (95% CI: £2394 to £7967) in the 
period following the index stay.  There is also considerable uncertainty around these cost 
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estimates as indicated by the confidence intervals.  The major drivers of cost were inpatient 
and outpatient services, district nursing and home care worker.  Comparatively few costs 
were specifically related to cognitive services, apart from memory clinics and some spending 
on memory related drugs.  There was also one GP home visit that was specified as related to 
memory assessment.  
 
Table 2: Estimated service use cost since discharge from hospital 
Service Category Mean cost 95% CI 
Inpatient Stays £699 £47 to £1351 
Outpatient Visits £767 -£113 to £1646 
Day Service Use £116 -£37 to £269 
Community Care Contacts £3,539 £1419 to £5658 
Cost of Memory related drug £60 -£16 to £136 
Total £5,180 £2394 to £7967 
 
Attitudes and experiences of dementia case-finding 
Two main themes emerged from the qualitative analysis (i) Attitudes and experiences of 
dementia case-finding and (ii) Patients’ and carers’ follow up experiences.  Examples quotes 
(Q = quotes) are given in Tables 3 and 4.  
Patients and carers were often unaware that memory assessments had taken place during 
their hospital admission and, in many cases, the patient had been assessed alone without a 
family carer being present or notified (Q1-2).  For those carers who were aware of the 
memory assessment, they lacked information about the purpose or outcome of the test. 
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Although some patients and carers did not mind having a memory test in hospital (Q3), 
others felt that it was inappropriate to conduct such tests when someone was acutely ill 
(Q4-6, 9-10).  Some patients reported feeling anxious about answering the memory 
questions incorrectly (Q7, Q8).  There were examples of poor practice in terms of the way 
the test had been administered, such as the test being administered in an insensitive 
manner (Q11).  Even when case-finding had flagged up a concern about a patient’s cognition 
this did not appear to have impacted on discharge planning or the involvement of carers 
(Q12, Q13).  For example, patients were being discharged with altered medication and the 
hospital did not inform the family carers (Q14, Q15).   
Table 3:  Quotes illustrating theme 1 
Quote Views and experiences of dementia case-finding 
1 I think someone did come to see him but they didn’t see me. (Carer 16) 
2 I don't think that was on his release papers neither 'cos they usually put things that 
he's had done on his release papers. (Carer 04) 
3 Didn’t worry me one bit. (Patient 21) 
4 …if there’s no medication or they’re not going to put you on treatment what’s the 
point. That’s my view. (Carer 03) 
5 I thought it very inappropriate when somebody’s in and they’re feeling really rough, 
their breathing is dreadful, full of pneumonia and all the rest of it (Carer 08) 
6 at two o'clock in the morning… We'd been in A&E for hours…They decided that Dad 
should stay because he had an infection, and they gave him the memory test…I 
remember saying, "You are having a laugh" (Carer 26) 
7 you feel as though they’re encroaching on your brain to try and make you make a 
mistake, that’s how I felt (Patient 05) 
8 
[about the test] …he was shattered, and I think he was frightened. (Carer 26)  
9 I would have thought that if there were to be any benefit gained it would be once 
the patient is stable. At admission, everything's frightening, worrying, they don't 
know what they're there for maybe or they're worried about what they're there for 
(Carer 23) 
10 I explained it, she’s more aware at home, I explained how bad she was in hospital to 
how different she is at home (Carer 02) 
11 “…doctor came in and she asked [patient] some questions and of course [patient] 
just doesn’t always understand because it’s the comprehension isn’t it, cognitive as 
well, and so [patient] said, “ask my wife”, and she said, “I am asking you” [said in an 
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abrupt manner] which made me prickle so I said, “well, [patient]’s dysphasic and you 
know, he does have difficulty…and I was really cross about that, I thought time and 
place”(Carer 08) 
12 Well I was a little bit confused really over the whole thing, you know, well I think the 
family were really. (Carer 01) 
13 I think they were just telling me that I had to get her to the doctors, to organise the 
Memory Clinic, I’m sure that’s what it was, they were telling me, but it wasn’t really 
clear, like I’m saying, I think she should have been sent home with some paperwork 
to say right, this is what is needed. (Carer 02) 
14 they changed her medication and they stopped that, so there must have been a 
reason for stopping it...but they didn't tell us, we had no way of knowing until three 
months later, which I think is frightening. (Carer 23) 
15 they were in a rush to get her out because she didn’t need any more treatment, 
albeit she was discharged taking an antibiotic and there was no indication what the 
antibiotic was for, or anything on the, it wasn’t included on the medications list. 
(Carer 07) 
 
Patients and carers’ follow up experiences  
There was a consistent pattern for patients and relatives in terms of their follow up 
experiences.  Most reported that they had not had a follow up discussion with their GP 
about the dementia case-finding outcomes or re-assessment of their cognition post 
discharge (Q16, Q17).  Even though some had seen a GP or practice nurse since leaving 
hospital, they reported that the issue of dementia case-finding had not been raised (Q18).  
Some carers contacted their GP about their relative’s memory but felt the follow-up was not 
always adequate (Q19-Q20).  One carer could not understand why the hospital did not deal 
with their relative’s memory problem since they had identified it and felt this was another 
issue for carers to take on board (Q21). 
Dementia case-finding did not appear to have impacted on service provision post-discharge.  
Relatively few new services appeared to have been instigated and others, such as OT 
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assessments and adjustments to the home, were not timely.  Whilst some families reported 
satisfaction with social care services, such as respite care (Q22), many others felt their needs 
were not being met.  For example, carers coming at inappropriate times and the provision of 
poor care (Q23-Q25). 
Table 4: Quotes illustrating theme 2 
Quote Patients’ and carers’ follow up experiences 
16 Well I mean, I’m a bit surprised that the GP hasn’t been to see her (Carer 01) 
17 I don’t feel the GP’s that interested. (Carer 16) 
18 I did, I prompted it. So how did you prompt it, what happened? 
Alright, I… I told the GP that she needs this test (Carer 06) 
19 No, that was me … [raised wife’s memory after unrelated GP visit] That was a good 
while ago and he’s never mentioned anything since.   (Carer 20) 
20 I’d asked his GP if he could have a psychiatric assessment and they sent round a CPN 
and she chatted to him and she said to me “oh yes, he has got dementia”, she said 
“I’m not quite sure what type, I’ll discuss it with the team” because the consultant 
was away at that time “and we’ll let you know”. Well she never did get back to me. 
(Carer 16) 
21  so why is it not dealt with in the hospital when they’re actually there, and they can 
see there’s a problem (Carer 02) 
22  I think it works well, like I said, it works well too that I’ve kind of got a bit of my life 
back…it definitely helps having carers three times a day. (Carer 02) 
23  We could not have managed without it. We were getting desperate – we could not 
manage, we couldn’t be there for long enough. (Carer 14) 
24 It’s not care, they just come in, write a bit in her folder and that is it, that is not care, 
they do not look after my mum (Carer 05) 
25  they come at so weird times. I mean, for instance, the other Sunday night they came 
at twenty past five to put her to bed. Have you ever heard of anything so stupid! 
(Carer 01) 
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DISCUSSION  
Dementia case-finding in acute hospitals involves the routine cognitive assessment of older 
people during an unplanned hospital stay and aims to improve the identification of patients 
with dementia in hospitals so that they could be flagged to their GP for further investigation 
and referral.  This study aimed to explore patients’ and their families’ experiences of how 
this worked in practice.  It was conducted in two acute hospital settings in the East of 
England where dementia case-finding was implemented with little or no evaluation of its 
effectiveness in terms of improving patient outcomes.  To our knowledge, this is the first 
study to explore the views and experiences of older patients and their family carers to case-
finding and to estimate the economic impact for the health service.  
We spoke to patients and carers of patients who had been identified as having a concern 
about their cognition during their hospital admission.  Although the median MMSE score of 
included participants at interview indicated that most patients had mild cognitive 
impairment, MMSE scores ranged from 6-30.  The findings from this study suggest that 
there was little follow up from patients’ GPs post discharge and few further investigations or 
referrals or medication instigated due to dementia case-finding outcomes; although in some 
cases, patients had already been seen by their GP prior to their hospital stay about their 
cognition.  The lack of follow up may not be surprising in light of the fact the outcomes of 
dementia case-finding are often poorly reported to GPs.27  
Patients and their families had mixed attitudes towards dementia case-finding but many did 
not remember the assessment and/or did not appear to have been informed about what 
this would mean in terms of their subsequent care and treatment.  There was also concern 
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that the acute hospital setting might not be the best place in which to assess cognition.  
Indeed, 10 former patients had MMSE scores which indicated no cognitive impairment 
despite having been picked up by the case-finding process when in hospital.  In a previous 
paper we reported that dementia case-finding has raised awareness about dementia within 
hospitals.27  However, delirium is often undetected in hospitals40 and can increase the 
likelihood of reporting false-positives and result in misdiagnosis of dementia.41 
The results of the costing evaluation showed that participants/patients had average costs of 
£5,180.  The mean length of time over which these costs were incurred was 283 days, 
excluding the initial stay.  Although these individuals had been identified from dementia 
case-finding the proportion of those costs attributed directly to services related to cognition 
appear to be small (approximately 6%).  This is not surprising as we found that few services 
had been instigated due to case-finding.  Whilst the costs of services initiated in the 
community following case-finding did not appear to be high, from health professionals’ 
reports of how case-finding has been implemented in the previous phase of the Cascade 
study27 it is likely that case-finding is associated with significant costs within the hospital 
itself, though to our knowledge no research to date has quantified these yet.  This suggests 
that an evaluation of the costs of such a policy, including the opportunity costs within the 
policy implementations system (Public Health England, NHS England) are warranted.  
Limitations 
The small sample size and the reliance on participants’ self-reporting are limitations of the 
study.  Recruiting in this setting is challenging and only a small proportion of those who have 
experienced hospital case-finding could be consulted for the study and may not be 
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representative of the patient group even within the single settings.  Patients found it 
difficult to correctly recall services received and the reason for those services.  Therefore, it 
was difficult to judge whether services received were a direct consequence of dementia 
case-finding.  Carers were responsible for coordinating their relative’s care and 
consequently carers were able to provide more information than patients. The participants 
in this study may not be representative of others elsewhere in the UK, although no other 
such study has taken place to our knowledge.  Since presentation of our findings to key 
policy makers the mandatory nature and financial incentives associated with dementia case-
finding are no longer in place.  The study remains relevant as moves to promote case-finding 
across health settings affect many countries and it serves as an illustration of the vital need 
to test policies before implementing them on the large scale.42 43  
Conclusions 
This study highlights that dementia case-finding in hospitals did not necessarily lead to a GP 
follow up or referrals for further investigation or lead to new supportive services being put 
in place.  Often patients and their family carers were not informed that memory 
assessments had been carried out whilst in hospital or what the outcomes of the 
assessment would mean in terms of their future care and treatment.  There is a need for a 
more evidence-based approach to the initiation of mandatory initiatives such as case-
finding.  This includes evaluation of the costs of such a policy, including the opportunity 
costs within the policy implementations system. 
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